Key facts
| Price (PPV) | 24,024 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | palbociclib |
| Class | Antineoplastic agents |
| ATC code | L01XE33 |
| Manufacturer | PFIZER MAROC |
| Presentation | Boite de 21 |
| Nature | Médicament |
| Hospital price | 23,561 MAD |
| Data collected on | 9/8/2026 |
Indications
IBRANCE est indiqué, en association avec le Létrozole, dans le traitement en première ligne du cancer du sein métastasique chez la femme ménopausée, positif pour le récepteur d’oestrogène (ER+) et négatif pour le récepteur 2 du facteur de croissance épidermique humain (HER2-) .
Find an open pharmacy
On-call pharmacies near you
About Ibrance 75 mg
Ibrance 75 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by PFIZER MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Ibrance 75 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Ibrance 75 mg
Answers to common questions from Moroccan patients about this drug.